Speciality Medicines Limited (BOM:544738)
363.05
+17.25 (4.99%)
At close: Apr 28, 2026
Speciality Medicines Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Cash & Equivalents | 8.46 | 2.49 | 2.62 | 0.77 |
| Cash & Short-Term Investments | 8.46 | 2.49 | 2.62 | 0.77 |
| Cash Growth | 239.81% | -4.83% | 241.00% | - |
| Accounts Receivable | 96.05 | 107.13 | 55.06 | 25.91 |
| Other Receivables | 7.57 | 7.35 | 7.45 | 1.64 |
| Receivables | 104.05 | 114.81 | 62.73 | 27.55 |
| Inventory | 173.76 | 80.31 | 45.95 | 4.83 |
| Other Current Assets | 77.94 | 11.88 | 2.11 | 2.35 |
| Total Current Assets | 364.21 | 209.49 | 113.4 | 35.5 |
| Property, Plant & Equipment | 18.67 | 14.71 | 16.93 | 19.08 |
| Long-Term Investments | 1.02 | 1 | 1 | 2.11 |
| Other Intangible Assets | 1.02 | 0.88 | 0.73 | 0.73 |
| Long-Term Deferred Tax Assets | - | 0.18 | - | 0.05 |
| Other Long-Term Assets | 15.24 | 7.02 | 0.3 | 0.3 |
| Total Assets | 400.15 | 233.27 | 132.35 | 57.76 |
| Accounts Payable | 9.71 | 24.15 | 18.02 | 11.83 |
| Accrued Expenses | 0.35 | 1.52 | 0.53 | 0.67 |
| Short-Term Debt | 11.95 | 17.25 | 16.91 | 11.78 |
| Current Portion of Long-Term Debt | 12.44 | 2.88 | - | - |
| Current Income Taxes Payable | 14.94 | 6.72 | - | 6.64 |
| Other Current Liabilities | 16.8 | 4.9 | 12.77 | 7.4 |
| Total Current Liabilities | 66.18 | 57.41 | 48.24 | 38.32 |
| Long-Term Debt | 26.08 | 8.45 | 19.49 | - |
| Pension & Post-Retirement Benefits | 1.24 | 0.6 | - | 0.12 |
| Long-Term Deferred Tax Liabilities | 0.43 | - | - | - |
| Other Long-Term Liabilities | - | - | 0.12 | - |
| Total Liabilities | 93.93 | 66.46 | 67.84 | 38.44 |
| Common Stock | 64.36 | 51.17 | 38.2 | 2.1 |
| Additional Paid-In Capital | 103.28 | 49.02 | - | 2.43 |
| Retained Earnings | - | - | 26.31 | 14.79 |
| Comprehensive Income & Other | 138.58 | 66.62 | - | - |
| Shareholders' Equity | 306.22 | 166.81 | 64.51 | 19.32 |
| Total Liabilities & Equity | 400.15 | 233.27 | 132.35 | 57.76 |
| Total Debt | 50.47 | 28.58 | 36.4 | 11.78 |
| Net Cash (Debt) | -42.01 | -26.09 | -33.78 | -11.01 |
| Net Cash Per Share | -6.53 | -5.10 | -9.44 | -3.62 |
| Filing Date Shares Outstanding | 6.44 | 6.44 | 3.82 | 3.04 |
| Total Common Shares Outstanding | 6.44 | 5.12 | 3.82 | 3.04 |
| Working Capital | 298.03 | 152.08 | 65.16 | -2.82 |
| Book Value Per Share | 47.58 | 32.60 | 16.89 | 6.36 |
| Tangible Book Value | 305.2 | 165.93 | 63.78 | 18.6 |
| Tangible Book Value Per Share | 47.42 | 32.43 | 16.70 | 6.12 |
| Land | 5.58 | - | - | - |
| Buildings | 15.75 | 15.75 | 15.74 | 15.75 |
| Machinery | 5.62 | 5.35 | 5.25 | 4.45 |
Source: S&P Capital IQ. Standard template. Financial Sources.